Techno Limits

Alan k
Posted: 03/01/2016

When it comes to integrating the pharma cold-chain, technology is invariably seen as having a big part to play. However, it can also form a big part of the problem. Here Alan Kennedy examines the virtues and limitations of technology when it comes to collaborative solutions.First of all, just in case I am in any danger of ruffling a few

To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Alan k
Posted: 03/01/2016

Join for Free


Amsterdam, The Netherlands
May 21 - 23, 2019
The Ritz-Carlton Coconut Grove, Miami, FL, United States
May 20 - 22, 2018

You Might Also Like

The FDA has published draft guidance proposing a 12 month grace period on the enforcement of... Read more
Contributor: Chanice Henry
Pharma M&As and Their Impacts On Cold Chain
Val Petursson, Managing Director PTC/PP & Logistics - Intl, Allergan speaks to Chanice Henry,... Read more
What’s on the horizon for GMP Compliance
At the recent MHRA GDP & GMP Symposium Martine Powell, GMDP inspector examined the known future... Read more
Contributor: Miss Chanice Henry
Top Content For 2015
Cold Chain IQ and Pharma IQ present the top content pieces for 2015 in this annual bumper, so you... Read more